Biggest Pharma company of the world for 172 years. World sales or around 3 Lakh Cr which is equal to all listed companeis sales while Profits of around 70k Cr. India Revenue and Profit has grown by around just 7% CAGR since 2001 as usually seen in MNC in India where not so attractive comparing it to Indian MNC. Indian MNC grew by around 15% during the same time. But Quality wise MNC are far better as they operate with low debt and better margins, Investors can expect consistent dividends in MNC. Considering Average growth in sales and due to qualtiy growth was transfered to Profits we saw investors value grew by around 15% CAGR during the past 2 Decades, we can even say value grew by 200X during the past 25 Years along with consistent and very high dividends. Good for retired people.
Many people in this group have held this company since 1000 just 5 years back and no need to hurry and sell as this is for wealth. Last year as Pharma companies started to revive many companies started to grow again. Annual results show muted 4% sales growth and 2% fall in profits. They have announced dividend of 320 v/s eps of 109 during this challenging time.
New buying again can be done during any fall near 4300 (Upgraded from 3400) & we may see Pfizer move in the long range of 5900 to 4300, 5900 was our target since the buying during 2017, so we have already recomended 5% profits booking near 5900 for those who added around 1800. Can even keep it for long term wealth.
LICMf hold around 23 Lakh shares which is 5% stake since long time and again added around 48000 shares just in this January. Birla Mf hold around 23 Lakh shares out of which they just added 9 lakh shares last year at 2700 and increased their stake from 5% to 7%. So all those from this group holding since 2014 at 1000 can hold like them to create wealth.